凝结
转甲状腺素
心内注射
发病机制
化学
细胞生物学
医学
心脏病学
内科学
生物
作者
Alvarez Rossi,Laura Acquasaliente,Daniele Peterle,N. Berti,Alessandro Negro,Guglielmo Verona,Julian D. Gillmore,Ornella Leone,S. Toffanin,Raimondo De Cristofaro,Francesco Cappelli,Federico Perfetto,Paolo Simioni,Vittorio Bellotti,Vincenzo De Filippis
标识
DOI:10.1016/j.rpth.2023.100791
摘要
determined that 5C12 binds to a 5 amino acid external loop I383APCW on FXIIa that is near the active-site H393.The C386W387 sequence is highly conserved in the FXII family of proteins: tPA, uPA, and HGFA.Competition inhibition assays using peptides IAPAW and IAPCA reveal that the cysteine and tryptophan in α-FXIIa are critical for 5C12 binding.Last, 5C12 is unable to immunoblot a FXII C386-C456 mutant. Conclusion(s):We postulate that 5C12 binding to FXIIa causes a change in the orientation of the active site histidine, incapacitating the catalytic triad.Use of anti-FXIIa Mabs may reduce or eliminate the need for heparin with medical devices.Presently, there is no agent like this approved for this therapeutic indication.
科研通智能强力驱动
Strongly Powered by AbleSci AI